[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100559858":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":22,"centralContacts":30,"locations":37,"responsibleParty":67,"collaborators":10,"id":69,"slug":70,"hasResults":71,"nctId":72,"briefTitle":73,"officialTitle":74,"acronym":10,"eligibilityCriteria":75,"healthyVolunteers":71,"sex":76,"minAge":10,"maxAge":10,"enrollmentInfo":77,"targetDuration":10,"studyType":80,"phases":10,"briefSummary":81,"conditions":82,"keywords":10,"overallStatus":40,"whyStopped":10,"lastUpdateSubmitDate":86,"lastUpdatePostDateStruct":87,"startDateStruct":90,"completionDateStruct":92,"leadSponsor":94,"locationsCount":95},{"fullName":5,"class":6},"Edwards Lifesciences","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Treatment",null,"Treatment with the Edwards EVOQUE Tricuspid Transcatheter Valve Replacement System",[13],"Device: Transcatheter Tricuspid Valve Replacement",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":20},"DEVICE","Transcatheter Tricuspid Valve Replacement","Replacement of the tricuspid valve through a transcatheter approach",[9],[21],"Edwards EVOQUE Tricuspid Valve Replacement System",[23,27],{"name":24,"affiliation":25,"role":26},"Volker Rudolph, Prof. MD","Herz-und Diabeteszentrum NRW, Bad Oeynhausen","PRINCIPAL_INVESTIGATOR",{"name":28,"affiliation":29,"role":26},"Fabien Praz, Prof. MD","Bern, Insespital, Switzerland",[31],{"name":32,"role":33,"phone":34,"phoneExt":35,"email":36},"TMTT Clinical","CONTACT","+1-949-250-2500 or","+1800-424-3278","TMTT_Clinical@Edwards.com",[38,53],{"facility":39,"status":40,"city":41,"state":10,"zip":10,"country":42,"countryCode":43,"cosmosGeoPoint":44,"geoPoint":49,"contacts":50},"Herz-und Diabeteszentrum NRW","RECRUITING","Bad Oeynhausen","Germany","DE",{"type":45,"coordinates":46},"Point",[47,48],8.80365,52.20699,{"lat":48,"lon":47},[51],{"name":24,"role":33,"phone":10,"phoneExt":10,"email":52},"vrudolph@hdz-nrw.de",{"facility":54,"status":55,"city":56,"state":10,"zip":10,"country":57,"countryCode":58,"cosmosGeoPoint":59,"geoPoint":63,"contacts":64},"Inselspital","NOT_YET_RECRUITING","Bern","Switzerland","CH",{"type":45,"coordinates":60},[61,62],7.44744,46.94809,{"lat":62,"lon":61},[65],{"name":28,"role":33,"phone":10,"phoneExt":10,"email":66},"fabien.praz@insel.ch",{"type":68,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100559858","real-world-european-investigation-of-safety-and-clinical-efficacy-of-the-evoque-system-triscend-iii-eu-100559858",false,"NCT06569602","Real World European Investigation of Safety and Clinical Efficacy of the EVOQUE System (TRISCEND III EU)","Edwards EVOQUE Transcatheter Tricuspid Valve Replacement: Real World European Investigation of Safety and Clinical Efficacy Using a Novel Device","Inclusion Criteria:\n\n1. The Local Site Heart Team determines that the patient is appropriate for transcatheter tricuspid valve replacement with the EVOQUE system per the current instructions for use.\n2. Patient agrees to attend follow-up assessments.\n3. Patients provided written informed consent for participation in the study.\n\nExclusion Criteria:\n\n1. Patient participating in another interventional biologic, drug, or device clinical study that has not met its primary endpoint(s).\n2. Any patient considered to be part of a vulnerable population.","ALL",{"count":78,"type":79},500,"ESTIMATED","OBSERVATIONAL","This is a prospective, single-arm, multi-center, real-world study of an the Edwards EVOQUE system.",[83,84,85],"Tricuspid Valve Regurgitation","Heart Valve Diseases","Cardiovascular Diseases","2024-10-29",{"date":88,"type":89},"2024-10-31","ACTUAL",{"date":91,"type":89},"2024-10-01",{"date":93,"type":79},"2033-09-30",{"name":5,"class":6},2]